title: [Actinic Keratosis].
abstract: Actinic keratosis is a cutaneous lesion characterized by proliferation of atypical epidermal keratinocytes due to prolonged exposure to exogenous factors such as ultraviolet radiation. AKs are in-situ-squamous cell carcinomas (PEC) of the skin. AK typically presents as erythematous, scaly patch or papule (classic AK), occasionally as thick, adherent scale on an erythematous base. Mostly fair-skinned adults are affected. AKs typically occur in areas of frequent sun exposure (balding scalp, face, "H-region", lateral neck, décolleté, dorsum of the hand and lower extremities). Actinic Cheilitis is the term used for AKs appearing on the lips. The diagnosis of AK is based on clinical examination including inspection and palpation. The typical palpable rough surface of AK often precedes a visible lesion. Dermoscopy may provide additional information. If diagnosis is uncertain and invasion suspected, biopsy and histopathologic evaluation should be performed. The potential for progression to invasive PECs mandates therapeutic intervention. Treatment options include topical and systemic therapies. Topical therapies are classified into physical, medical and combined physical-chemical approaches and a sequential combination of treatment modalities is possible. Topical-physical cryotherapy is the treatment of choice for isolated, non-hypertrophic AK. Topical-medical treatment, e. g. 5-fluoruracil (5FU) cream or Imiquomod or Ingenolmebutat application is used for multiple, non-hypertrophic AKs. For hypertrophic AKs, a dehorning pretreatment with salicinated vaseline is recommended. Isolated hypertrophic AKs often need cryotherapy with prolonged freezing time or several consecutive applications. Sequentially combined approaches are recommended for multiple, hypertrophic AKs. Photodynamic therapy (PDT) as example for a combined physical-chemical approach is an established treatment for multiple, non-hypertrophic and hypertrophic AKs. Prevention includes avoidance of sun and application of sunscreen with high sun protection factor. Regular clinical checkups aid in early recognition of AKs.
authors.affiliation: Klinik für Hals-, Nasen- und Ohrenheilkunde, Medizinische Universität Innsbruck.
authors.forename: D
authors.initials: D
authors.lastname: Dejaco
authors.affiliation: Klinik für Dermatologie und Venerologie, Medizinische Universität Innsbruck.
authors.forename: U
authors.initials: U
authors.lastname: Hauser
authors.affiliation: Klinik für Dermatologie und Venerologie, Medizinische Universität Innsbruck.
authors.forename: B
authors.initials: B
authors.lastname: Zelger
authors.affiliation: Klinik für Hals-, Nasen- und Ohrenheilkunde, Medizinische Universität Innsbruck.
authors.forename: H
authors.initials: H
authors.lastname: Riechelmann
mesh_terms: D002278:Carcinoma in Situ / Q000175:diagnosis* / Q000473:pathology* / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis* / Q000473:pathology* / Q000628:therapy; D046169:Dermoscopy; D006801:Humans; D055623:Keratosis, Actinic / Q000175:diagnosis* / Q000473:pathology* / Q000628:therapy; D009378:Neoplasms, Multiple Primary / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D009381:Neoplasms, Radiation-Induced / Q000175:diagnosis* / Q000473:pathology* / Q000628:therapy; D012867:Skin / Q000473:pathology